Under the Microscope
Feb. 15, 2012

Box keeps donated hearts beating longer
Laboratory Equipment
New technology increases the length of time that a human heart can remain viable for transplant after removal from a donor for transplantation. A clinical trial already underway in the United States is evaluating the new technology, called the Organ Care System, which aims to keeps donated hearts viable for hours longer than currently possible.More

Creating the perfect laboratory
Laboratory News
Oxford University's new research laboratories have been designed by Make Architects and Nightingale Associates — Laboratory News learns what goes into making the perfect lab. This article explore what it takes to remain the world's highest ranked medical research facility.More

Genetic Parkinson's disease brain cells made in lab
BBC News
Scientists in the U.S. have successfully made human brain cells in the lab that are an exact replica of genetically caused Parkinson's disease. The breakthrough means they can now see exactly how mutations in the parkin gene cause the disease in an estimated 1 in 10 patients with Parkinson's.More

2012 student scholarships
NSH
NSH offers $500 student scholarships, made possible by Newcomer Supply, Sigma, ThermoScientific and Sakura Finetek. Applicants must be registered as student members with NSH. Students must submit application form with plans for utilization and a recommendation letter from instructor or supervisor. The awards committee will consider your application for a student scholarship only when all supporting documents are received and your application is complete.

Recommendation letters may be sent to histo@NSH.org or by fax to: 443-535-4055 or mail to: NSH Student Scholarship Committee, 10320 Little Patuxent Pkwy, Suite 804, Columbia, MD 21044

The deadline for student scholarships is March 16. Recipients will be notified via email on April 16.More

Artificial immune cell treatment for melanoma aims for human trials in 2013
MedCity News
A new treatment for cancer that uses artificial immune cells to trigger the body to kill cancerous cells will raise a series A round this spring and look to an investigational new drug application next year. NexImmune is an early stage biopharmaceutical company engineering artificial cells that can stimulate the immune system to treat cancer, transplant rejection, autoimmunity and infectious diseases.More

How infections call for more blood
The University of Auckland via Science Alert
Research at The University of Auckland-New Zealand has shed light on an area of medicine which has intrigued the international scientific community for decades. Scientists at the Faculty of Medical and Health Sciences have identified a molecular mechanism which links infection to an increase in rare blood stem cells in an animal.More

Male genes may explain higher heart disease risk
The New York Times
Although heart disease is the leading killer of women as well as of men, two heart disease patients out of every three are male, and heart disease strikes men 10 to 15 years earlier than it does women. No one really knows why. Now, a new study reports that part of the answer may lie on the Y chromosome, the one chromosome unique to men.More

Protein starves HIV, thus protecting cells
Medical News Today
A protein called SAMHD1 has been found to starve HIV in cells so that it cannot do anything, thus making the cell resistant to HIV infection, researchers at New York University Langone Medical Center reported in Nature Immunology. The authors explained that their discovery could pave the way for new therapeutic research at halting or slowing the HIV's progression to AIDS.More

Pressurising red blood cells for information
Royal Society of Chemistry
Scientists in Canada have developed a method to study the changes in red blood cells caused by the most common malaria parasite Plasmodium falciparum. Current methods to measure deformability are complicated or not sensitive enough.More

Microrockets may someday power through the stomach
R&D Magazine
Scientists have developed a new kind of tiny motor — which they term a "microrocket" — that can propel itself through acidic environments, such as the human stomach, without any external energy source, opening the way to a variety of medical and industrial applications. Their report in the Journal of the American Chemical Society describes the microrockets traveling at virtual warp speed for such devices. A human moving at the same speed would have to run at a clip of 400 miles per hour.More

The quest for pediatric reference ranges
Clinical Laboratory News
Studies funded by the American Association for Clinical Chemistry are now underway on early samples from the National Children's Study, an effort that leaders in the lab community hope will jump-start collaboration with diagnostic companies, commercial labs and academia to improve pediatric reference ranges.More